NCT00843960

Medication Adherence Enhancement in Heart Transplant Recipients

Medication Adherence Enhancement in Heart Transplant Recipients: a Randomized Clinical Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (estimated)
• Sponsor: Hannover Medical School · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Medication-related non-adherence increases the risk of rejections and associated graft loss after solid organ transplantation. A randomized controlled intervention will use adherence enhancing strategies out of a larger sample of 300 heart transplant recipients. Non-Adherence will be assessed by patients' self-report and based on immunosuppression level. All non-adherent patients will be randomly designed to either intervention or control group. Multi-module interventions include patient education, electronic medication event monitoring, and a combined behavior and symptom management. Longitudinal follow-up is envisioned after initial intervention.

Conditions

• Medication Adherence
• Self Management
• Rejection

Interventions

Type	Name	Description
BEHAVIORAL	behavioral adaptation and symptom management	behavioral adaptation and symptom management

Timeline

• Start date: 2009-02-01
• Primary completion: 2010-01-01
• Completion: 2013-12-01
• First posted: 2009-02-13
• Last updated: 2009-10-07

Locations

1 site across 1 country: Germany